0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Pathophysiology of Neurofibromatosis Type 1

Amy Theos, MD; and Bruce R. Korf, MD, PhD
[+] Article and Author Information

From the University of Alabama at Birmingham, Birmingham, Alabama.


Potential Financial Conflicts of Interest: Grants received: B.R. Korf (National Institutes of Health, U.S. Army).

Requests for Single Reprints: Bruce R. Korf, MD, PhD, Department of Genetics, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294; e-mail, bkorf@uab.edu.

Current Author Addresses: Dr. Theos: Department of Dermatology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294.

Dr. Korf: Department of Genetics, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294.


Ann Intern Med. 2006;144(11):842-849. doi:10.7326/0003-4819-144-11-200606060-00010
Text Size: A A A

Neurofibromatosis type 1 is a highly variable disorder with signs and symptoms that may begin at birth and evolve over a lifetime. Phenotypic features can be broadly divided into tumors and nontumor manifestations.

First Page Preview

View Large
First page PDF preview

Figures

Grahic Jump Location
Figure 1.
Several dermal neurofibromas that are visible as raised lesions but are sometimes first detected by palpation.

The distance between each hash mark is 1 cm.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Angiogram showing renal artery stenosis in a patient with neurofibromatosis type 1.
Grahic Jump Location
Grahic Jump Location
Figure 3.
Skeletal dysplasias in neurofibromatosis type 1.Top.Bottom.

Dysplasia of tibia and fibula. Computed tomography scan showing dysplasia of thoracic vertebra.

Grahic Jump Location
Grahic Jump Location
Figure 4.
Ras signaling pathway.GDPGTP

Binding of ligand to membrane tyrosine kinase receptor results in conversion of Ras–guanosine diphosphate ( ) to Ras–guanosine triphosphate ( ). This leads to a cascade of activation of other proteins (“effector pathways”), which eventually results in activation of transcription of specific genes. Shc, Grb2, SoS, Raf, Mek, and Erk are additional proteins in the Ras signal transduction pathway. NF1 = neurofibromatosis type 1; P = phosphate

Grahic Jump Location
Grahic Jump Location
Figure 5.
Formation of neurofibroma.NF1

A Schwann cell that is heterozygous for an mutation (+/−) undergoes mutation to −/−. This cell proliferates and also attracts other cells, including fibroblasts, perineurial cells, and mast cells, to proliferate in the lesion.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)